首页> 外文期刊>Molecular cancer research: MCR >Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.
【24h】

Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.

机译:外源性组织因子对乳腺癌细胞中雌激素受体α表达的影响:β1整合素,PAR2和有丝分裂原激活的蛋白激酶激活的参与。

获取原文
获取原文并翻译 | 示例
           

摘要

Increased expression of tissue factor (TF) has been associated with invasive forms of breast cancer. Conversely, the loss of estrogen receptor alpha (ERalpha) is associated with increased cell invasiveness. We have examined the influence of exogenous truncated recombinant TF (rTF) on ERalpha expression and cell invasiveness and investigated the mechanism of rTF signaling. The influence of rTF on ERalpha expression in MCF-7 and T47D cell lines was investigated using reverse transcription-PCR and ELISA. Cell invasion was measured using Boyden chamber-based invasion assays. Additionally, the interaction of fluorescein-labeled rTF with the surface of MCF-7 cells and particularly with beta(1)-integrin was examined. Treatment of cells with rTF resulted in the down-regulation of ERalpha mRNA and protein over 24 h, which required beta(1)-integrin and involved the mitogen-activated protein kinase pathway but did not require PAR2 activation. The addition of rTF reduced estradiol-mediated cell proliferation as well as increased cell invasiveness requiring both PAR2 and beta(1)-integrin activation. Fluorescein-labeled rTF was shown to bind to the surface of MCF-7 cells within 5 min and peaked at 15 min. The bound rTF colocalized with cellular beta(1)-integrin and was disrupted in the presence of excess unlabeled rTF and an anti-beta(1) polyclonal antibody. Finally, affinity purification of beta(1)-integrin using rTF-conjugated agarose showed a requirement for the presence of divalent cations but not factor VIIa. The results indicate that rTF is capable of down-regulating ERalpha expression in breast cancer cells, resulting in decreases in estrogen-mediated cell proliferation and increased invasiveness. Furthermore, the mechanisms by which rTF induces these changes involve both PAR2 and beta(1)-integrin.
机译:组织因子(TF)表达的增加与乳腺癌的浸润性形式有关。相反,雌激素受体α(ERalpha)的丢失与细胞侵袭性增加有关。我们已经检查了外源截短的重组TF(rTF)对ERalpha表达和细胞侵袭性的影响,并研究了rTF信号传导的机制。使用逆转录PCR和ELISA研究了rTF对MCF-7和T47D细胞系中ERalpha表达的影响。使用基于博登室的侵袭测定法测量细胞侵袭。此外,检查了荧光素标记的rTF与MCF-7细胞表面的相互作用,尤其是与β(1)-整合素的相互作用。用rTF处理细胞会导致ERalpha mRNA和蛋白在24小时内下调,这需要β(1)-整合素并涉及丝裂原激活的蛋白激酶途径,但不需要PAR2激活。 rTF的添加减少了雌二醇介导的细胞增殖,并增加了需要PAR2和beta(1)-整合素激活的细胞侵袭性。荧光素标记的rTF已显示在5分钟内与MCF-7细胞表面结合,并在15分钟时达到峰值。结合的rTF与细胞β(1)-整合素共定位,并在存在过量未标记rTF和抗β(1)多克隆抗体的情况下被破坏。最后,使用rTF缀合的琼脂糖亲和力纯化β(1)-整合素表明,存在二价阳离子而不是VIIa因子的要求。结果表明,rTF能够下调乳腺癌细胞中的ERalpha表达,从而导致雌激素介导的细胞增殖减少和侵袭性增加。此外,rTF诱导这些变化的机制涉及PAR2和beta(1)整合素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号